Hormonal cross-talk of ER with PR-A is a fundamental mechanism that promotes the invasiveness and metastatic potential of HR-positive breast cancers by suppressing the regulation of critical microRNAs by estrogen [4]. This evidence concerns the gene ESR1 and breast carcinoma.